Operating Lease, Right-of-Use Asset in USD of Sonnet BioTherapeutics Holdings, Inc. from Q4 2018 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Sonnet BioTherapeutics Holdings, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2018 to Q2 2025.
  • Sonnet BioTherapeutics Holdings, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Jun 2025 was $64,640, a 54.4% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Sonnet BioTherapeutics Holdings, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $64,640 -$77,173 -54% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q3
Q1 2025 $84,851 -$74,790 -47% 31 Mar 2025 10-Q 13 May 2025 2025 Q2
Q4 2024 $104,435 -$72,491 -41% 31 Dec 2024 10-Q 13 Feb 2025 2024 Q1
Q3 2024 $123,417 -$70,272 -36% 30 Sep 2024 10-Q 13 Aug 2025 2025 Q3
Q2 2024 $141,813 -$68,131 -32% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q3
Q1 2024 $159,641 -$66,068 -29% 31 Mar 2024 10-Q 14 May 2024 2024 Q2
Q4 2023 $176,926 -$64,445 -27% 31 Dec 2023 10-Q 14 Feb 2024 2024 Q1
Q3 2023 $193,689 -$62,905 -25% 30 Sep 2023 10-K 17 Dec 2024 2024 FY
Q2 2023 $209,944 -$61,367 -23% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q3
Q1 2023 $225,709 +$147,709 +189% 31 Mar 2023 10-Q 10 May 2023 2023 Q2
Q4 2022 $241,371 +$140,393 +139% 31 Dec 2022 10-Q 13 Feb 2023 2023 Q1
Q3 2022 $256,594 +$133,381 +108% 30 Sep 2022 10-K 14 Dec 2023 2023 FY
Q2 2022 $271,311 +$126,524 +87% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q3
Q1 2022 $78,000 -$87,773 -53% 31 Mar 2022 10-Q 10 May 2022 2022 Q2
Q4 2021 $100,978 -$85,222 -46% 31 Dec 2021 10-Q 08 Feb 2022 2022 Q1
Q3 2021 $123,213 -$82,706 -40% 30 Sep 2021 10-K 15 Dec 2022 2022 FY
Q2 2021 $144,787 -$80,278 -36% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q3
Q1 2021 $165,773 -$11,090,724 -99% 31 Mar 2021 10-Q 17 May 2021 2021 Q2
Q4 2020 $186,200 -$11,481,826 -98% 31 Dec 2020 10-Q 16 Feb 2021 2021 Q1
Q3 2020 $205,919 -$14,318,544 -99% 30 Sep 2020 10-K 17 Dec 2021 2021 FY
Q2 2020 $225,065 -$17,487,929 -99% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q3
Q1 2020 $11,256,497 -$7,406,438 -40% 31 Mar 2020 10-Q 18 May 2020 2020 Q1
Q4 2019 $11,668,026 -$8,155,176 -41% 31 Dec 2019 10-Q 18 May 2020 2020 Q1
Q3 2019 $14,524,463 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 $17,712,994 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $18,662,935 31 Mar 2019 10-Q 15 May 2019 2019 Q1
Q4 2018 $19,823,202 02 Jan 2019 10-K 19 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.